Ligand validation:8XE0

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 8XE0 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8XE0_SAH_A_503	79%	29%	0.103	0.95	1.2	1.64	3	4	1	0	100%	1
8XE0_SAH_B_302	72%	28%	0.122	0.945	1.2	1.66	3	4	1	0	100%	1
8XDO_SAH_B_302	99%	26%	0.046	0.985	1.12	1.88	3	5	0	0	100%	1
8XDR_SAH_A_302	97%	27%	0.062	0.979	1.2	1.73	2	5	1	0	100%	1
8XDP_SAH_A_603	96%	29%	0.065	0.975	1.18	1.65	2	6	0	0	100%	1
8XDQ_SAH_A_604	95%	28%	0.067	0.973	1.17	1.71	2	4	1	0	100%	1
8XDU_SAH_A_503	94%	30%	0.074	0.972	1.21	1.57	2	4	1	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8TDR_SAH_B_1001	100%	25%	0.029	0.996	1.26	1.79	3	4	0	0	100%	1
6I73_SAH_A_401	100%	49%	0.028	0.992	0.78	1.16	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.